Psychedelics as Psychiatric Medications

David Nutt · David Castle

ମାର୍ଚ୍ଚ 2023 · Oxford University Press

ଇବୁକ୍

152

ପୃଷ୍ଠାଗୁଡ଼ିକ

ଯୋଗ୍ୟ

ରେଟିଂ ଓ ସମୀକ୍ଷାଗୁଡ଼ିକୁ ଯାଞ୍ଚ କରାଯାଇନାହିଁ ଅଧିକ ଜାଣନ୍ତୁ

ଏହି ଇବୁକ୍ ବିଷୟରେ

There is substantial contemporary interest in psychedelic agents as medicines for maladies of the mind. This follows research in the 1950s and 1960s exploring the use of LSD and other psychedelics to treat a range of psychiatric illnesses as well as addictions. This research was shut down after prohibition of these drugs, however the last decade has seen a major renewal of interest in the therapeutic use of psychedelics and related drugs in psychiatry. Psilocybin (found in 'magic mushrooms') has been used effectively for amelioration of distress in people with depression/anxiety in the context of potentially life-ending cancers, as well as for treatment-resistant depression and also addictions. MDMA ('ecstasy') has shown efficacy for severe post-traumatic stress disorder, with enduring benefit. Other psychedelics, both plant-derived (e.g., ayahuasca) and synthetically produced (e.g., LSD) are also being investigated for their potential therapeutic value. These agents not only herald a new neurobiology but also allow an integration of psychotherapy with biological compounds that is truly novel and that challenges established psychiatric practice. Furthermore, the action of these agents on the brain allows an exploration of how the brain works to 'open up' to psychotherapeutic healing. Published as part of the Oxford Psychiatry Library series, the book provides an overview of this hugely exciting field, covering the history of psychedelics, clinical aspects, risks and side effects, precautions and processes.

ଲେଖକଙ୍କ ବିଷୟରେ

David Nutt is a psychiatrist and the Edmond J. Safra Professor of Neuropsychopharmacology in Imperial College London. He is currently Founding Chair of the charity DrugScience.org.uk and has been president of the European Brain Council, the BAP, BNA, and ECNP. David has published 35 books and over 1000 research papers that define his many landmark contributions to psychopharmacology including GABA and noradrenaline receptor function in anxiety disorders, serotonin function in depression, endorphin and dopamine function in addiction and the neuroscience and clinical utility of psychedelics. Some of this has been made into films e.g. on Netflix and on the BBC and a play . He broadcasts widely to the general public on pharmacology and psychiatric matters, has over 60k followers on twitter and has his own very popular podcast... David Castle is Inaugural Scientific Director of the Centre for Complex Interventions (CCI) at the Centre for Addictions and Mental Health (CAMH), Toronto, Canada; and Professor, Department of Psychiatry, The University of Toronto. He has wide clinical and research interests, encompassing schizophrenia and related disorders, bipolar disorder, OCD spectrum disorders and disorders of body image. He has a longstanding interest in the impact of licit and illicit substances on the brain and body, and is actively engaged in a series of trials investigating psychedelics as psychiatric medicines. He has published widely and is a frequent speaker at scientific meetings.

ଏହି ଇବୁକ୍‍କୁ ମୂଲ୍ୟାଙ୍କନ କରନ୍ତୁ

ଆପଣ କଣ ଭାବୁଛନ୍ତି ତାହା ଆମକୁ ଜଣାନ୍ତୁ।

ପଢ଼ିବା ପାଇଁ ତଥ୍ୟ

ସ୍ମାର୍ଟଫୋନ ଓ ଟାବଲେଟ

Google Play Books ଆପ୍କୁ, Android ଓ iPad/iPhone ପାଇଁ ଇନଷ୍ଟଲ୍ କରନ୍ତୁ। ଏହା ସ୍ଵଚାଳିତ ଭାବେ ଆପଣଙ୍କ ଆକାଉଣ୍ଟରେ ସିଙ୍କ ହୋ‍ଇଯିବ ଏବଂ ଆପଣ ଯେଉଁଠି ଥାଆନ୍ତୁ ନା କାହିଁକି ଆନଲାଇନ୍ କିମ୍ବା ଅଫଲାଇନ୍‍ରେ ପଢ଼ିବା ପାଇଁ ଅନୁମତି ଦେବ।

ଲାପଟପ ଓ କମ୍ପ୍ୟୁଟର

ନିଜର କମ୍ପ୍ୟୁଟର୍‍ରେ ଥିବା ୱେବ୍ ବ୍ରାଉଜର୍‍କୁ ବ୍ୟବହାର କରି Google Playରୁ କିଣିଥିବା ଅଡିଓବୁକ୍‍କୁ ଆପଣ ଶୁଣିପାରିବେ।

ଇ-ରିଡର୍ ଓ ଅନ୍ୟ ଡିଭାଇସ୍‍ଗୁଡ଼ିକ

Kobo eReaders ପରି e-ink ଡିଭାଇସଗୁଡ଼ିକରେ ପଢ଼ିବା ପାଇଁ, ଆପଣଙ୍କୁ ଏକ ଫାଇଲ ଡାଉନଲୋଡ କରି ଏହାକୁ ଆପଣଙ୍କ ଡିଭାଇସକୁ ଟ୍ରାନ୍ସଫର କରିବାକୁ ହେବ। ସମର୍ଥିତ eReadersକୁ ଫାଇଲଗୁଡ଼ିକ ଟ୍ରାନ୍ସଫର କରିବା ପାଇଁ ସହାୟତା କେନ୍ଦ୍ରରେ ଥିବା ସବିଶେଷ ନିର୍ଦ୍ଦେଶାବଳୀକୁ ଅନୁସରଣ କରନ୍ତୁ।

ବେଆଇନ ବିଷୟବସ୍ତୁର ରିପୋର୍ଟ କର